ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near Austin, TX, USA:

A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer (AEGEAN)

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Paclitaxel
Procedure: Surgery

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 230 other locations

This is an open-label, non-controlled study conducted in two parts - Part A (dose escalation) followed by Part B (dose expansion)....

Active, not recruiting
Colorectal Cancer
Pancreatic Cancer
Drug: NBF-006

Phase 1

Nitto BioPharma

Austin, Texas, United States and 8 other locations

in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...

Enrolling
Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Drug: furmonertinib 240 mg oral, daily
Drug: furmonertinib 160 mg oral, daily

Phase 3

ArriVent BioPharma
ArriVent BioPharma

Austin, Texas, United States and 197 other locations

with osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC)....

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

Austin, Texas, United States and 30 other locations

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patien...

Enrolling
Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Adagrasib

Phase 2, Phase 3

Mirati Therapeutics
Mirati Therapeutics

Austin, Texas, United States and 155 other locations

and overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actio...

Enrolling
Non-small Cell Lung Cancer
Drug: Domvanalimab
Drug: Nab-paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

Austin, Texas, United States and 206 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell...

Enrolling
Head and Neck Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Drug: Budigalimab
Drug: ABBV-514

Phase 1

AbbVie
AbbVie

Austin, Texas, United States and 22 other locations

with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression on or after...

Active, not recruiting
Metastatic Non-Squamous Non-Small Cell Lung Cancer
Drug: Sitravatinib
Drug: Docetaxel

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Austin, Texas, United States and 233 other locations

by durvalumab in participants with untreated Locally Advanced Non-small Cell Lung Cancer (LA NSCLC)....

Active, not recruiting
Non-Small Cell Lung Cancer (NSCLC)
Biological: durvalumab
Biological: nivolumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 182 other locations

in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK11, K...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Pembrolizumab
Drug: Pemetrexed

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 67 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems